
Motus GI Holdings MOTS
Quartalsbericht 2024-Q1
hinzugefügt 14.05.2024
Motus GI Holdings ROE 2011-2026 | MOTS
ROE Jährlich Motus GI Holdings
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -478.86 | -624.69 | -197.09 | -170.57 | -125.96 | -120.2 | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -120.2 | -624.69 | -286.23 |
ROE Vierteljährlich Motus GI Holdings
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 458.54 | 823.57 | 172.12 | -587.43 | -1028.05 | -836.75 | -871.76 | -255.32 | -152.87 | -85.9 | -120.78 | -120.65 | -132.76 | -131.61 | -159.96 | -153.42 | -145.36 | -93.57 | -121.49 | -121.06 | -112.73 | -90.13 | -147.44 | -176.82 | -217.17 | -170.67 | -170.67 | -113.36 | -50.35 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 823.57 | -1028.05 | -169.44 |
ROE anderer Aktien in der Diagnostik & Forschung
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 16.19 | 0.5 % | $ 174 M | ||
|
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
22.45 | $ 117.7 | 2.28 % | $ 35.8 B | ||
|
Aspira Women's Health
AWH
|
184.36 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M | ||
|
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
-7.05 | $ 16.76 | 4.42 % | $ 893 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M | ||
|
Interpace Biosciences
IDXG
|
109.89 | $ 2.2 | -4.35 % | $ 9.73 M | ||
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
-227.33 | $ 1.43 | 4.38 % | $ 1.9 M | ||
|
Exact Sciences Corporation
EXAS
|
-8.66 | - | - | $ 19.8 B | ||
|
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
4.0 | $ 23.18 | 0.22 % | $ 644 M | ||
|
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
-4.56 | $ 177.87 | 1.25 % | $ 8.82 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | ||
|
Medpace Holdings
MEDP
|
98.27 | $ 498.89 | 1.09 % | $ 14.4 B | ||
|
Danaher Corporation
DHR
|
6.88 | $ 194.47 | 2.58 % | $ 139 B | ||
|
Myriad Genetics
MYGN
|
-99.43 | $ 4.59 | 5.4 % | $ 425 M | ||
|
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | ||
|
NeoGenomics
NEO
|
-12.91 | $ 7.95 | 3.38 % | $ 1.02 B | ||
|
Illumina
ILMN
|
-51.54 | $ 126.18 | 4.34 % | $ 20.1 B | ||
|
Fulgent Genetics
FLGT
|
-3.77 | $ 15.34 | 6.31 % | $ 464 M | ||
|
Guardant Health
GH
|
419.18 | $ 80.98 | 3.03 % | $ 10.2 B | ||
|
QIAGEN N.V.
QGEN
|
11.25 | - | - | $ 10.6 B | ||
|
Senseonics Holdings
SENS
|
-113.21 | $ 6.69 | 0.15 % | $ 279 M | ||
|
Anixa Biosciences
ANIX
|
-72.07 | $ 2.77 | 2.79 % | $ 89.9 K | ||
|
Biomerica
BMRA
|
-121.14 | $ 2.07 | -3.05 % | $ 4.75 M | ||
|
Invitae Corporation
NVTA
|
-98.02 | - | - | $ 21.2 M | ||
|
Koninklijke Philips N.V.
PHG
|
9.97 | $ 28.52 | 0.76 % | $ 20 B | ||
|
ICON Public Limited Company
ICLR
|
8.31 | $ 110.04 | 3.02 % | $ 9.08 B | ||
|
Soleno Therapeutics
SLNO
|
4.64 | $ 52.64 | 0.01 % | $ 2.68 B | ||
|
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 263.77 | 1.09 % | $ 21.9 B | ||
|
Natera
NTRA
|
-77.62 | $ 199.3 | 3.25 % | $ 19.6 B | ||
|
Celcuity
CELC
|
-176.06 | $ 119.06 | 1.64 % | $ 5.57 B | ||
|
Lantheus Holdings
LNTH
|
21.43 | $ 80.85 | 0.32 % | $ 5.46 B | ||
|
Neuronetics
STIM
|
-174.27 | $ 1.37 | 1.11 % | $ 90.4 M | ||
|
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 190.84 | -0.36 % | $ 21.2 B | ||
|
Neogen Corporation
NEOG
|
-52.72 | $ 9.32 | -1.01 % | $ 2.02 B | ||
|
ENDRA Life Sciences
NDRA
|
-310.93 | $ 4.97 | 0.61 % | $ 3.91 M | ||
|
Organovo Holdings
ONVO
|
-23.71 | - | -2.3 % | $ 19.4 M |